Litcius/Paper detail

In vivo activated T cell targeting with PD-1/PD-L1 blockade for sequential treatment mediated cancer immunotherapy

Weijing Yang, Meng Zhang, Jinjie Zhang, Yanlong Liu, Jie Ning, Jing Yang, Zhenzhong Zhang, Lin Hou, Xiaoyuan Chen

2022Nano Today15 citationsDOI

Topics & Concepts

ImmunotherapyCancer researchCancer immunotherapyBlockadeT cellIn vivoImmune checkpointImmune systemChemistryMedicineImmunologyReceptorBiologyBiochemistryBiotechnologyNanoplatforms for cancer theranosticsCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
In vivo activated T cell targeting with PD-1/PD-L1 blockade for sequential treatment mediated cancer immunotherapy | Litcius